参考文献/References:
[1]Brunelli N,Altamura C,Costa CM,et al.Carotid Artery Plaque Progression: Proposal of a New Predictive Score and Role of Carotid Intima-Media Thickness[J].Int J Environ Res Public Health,2022,19(2):758.[2]Ren H,Zhao L,Zou Y,et al.Association between atherosclerotic cardiovascular diseases risk and renal outcome in patients with type 2 diabetes mellitus[J].Ren Fail,2021,43(1):477-487.[3]于丽娜,耿巍,房伟,等.高脂饮食联合内膜损伤对动脉粥样硬化的作用及对炎症因子的影响[J].医学信息,2022,35(2):79-82. [4]Tan?覦nd?覦 A,Erkan AF,Alhan A,et al.Arterial stiffness and central arterial wave reflection are associated with serum uric acid, total bilirubin, and neutrophil-to-lymphocyte ratio in patients with coronary artery disease[J].Anatol J Cardiol,2015,15(5):396-403.[5]Wen G,Yao L,Hao Y,et al.Bilirubin ameliorates murine atherosclerosis through inhibiting cholesterol synthesis and reshaping the immune system[J].J Transl Med,2022,20(1):1.[6]Lapenna D,Ciofani G,Pierdomenico SD,et al.Association of serum bilirubin with oxidant damage of human atherosclerotic plaques and the severity of atherosclerosis[J].Clin Exp Med,2018,18(1):119-124.[7]Tao X,Wu J,Wang A,et al.Lower Serum Indirect Bilirubin Levels are Inversely Related to Carotid Intima-Media Thickness Progression[J].Curr Neurovasc Res,2019,16(2):148-155.[8]秦璐,谷永胜,李琳,等.健康体检人群血清胆红素水平对颈动脉粥样硬化进展影响的队列研究[J].中国全科医学,2022,25(13):1576-1581.[9]Lee I,Lee HH,Cho Y,et al.Association Between Serum Bilirubin and the Progression of Carotid Atherosclerosis in Type 2 Diabetes[J].J Lipid Atheroscler,2020,9(1):195-204.[10]Durante W.Targeting Heme Oxygenase-1 in the Arterial Response to Injury and Disease[J].Antioxidants (Basel) ,2020,9(9):829.[11]Wu G,Zhang J,Zhao Q,et al.Molecularly Engineered Macrophage-Derived Exosomes with Inflammation Tropism and Intrinsic Heme Biosynthesis for Atherosclerosis Treatment[J].Angew Chem Int Ed Engl,2020,59(10):4068-4074.[12]Borghi C,Desideri G.Urate-lowering drugs and prevention of cardiovascular disease: The emerging role of xanthine oxidase inhibition[J].Hypertension,2016,67(3):496-498.[13]Chen C,Lü JM,Yao Q.Hyperuricemia-Related Diseases and Xanthine Oxidoreductase (XOR) Inhibitors: An Overview[J].Med Sci Monit,2016,22:2501-2512.[14]Sun N,Zhang Y,Tian JL,et al.Relationship between uric acid and arterial stiffness in the elderly with metabolic syndrome components[J].Chin Med J,2013,126(16):3097-3102.[15]Lee TS,Lu TM,Chen CH,et al.Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine/dimethylarginine dimethylaminotransferase 2 pathway[J].Redox Biol,2021,46:102108.[16]Gherghina ME,Peride I,Tiglis M,et al.Uric Acid and Oxidative Stress-Relationship with Cardiovascular, Metabolic, and Renal Impairment[J].Int J Mol Sci,2022,23(6):3188.[17]Polito L,Bortolotti M,Battelli MG,et al.Xanthine oxidoreductase: A leading actor in cardiovascular disease drama[J].Redox Biol,2021,48:102195.[18]De Lima Balico L,Gaucher EA.CRISPR-Cas9-mediated reactivation of the uricase pseudogene in human cells prevents acute hyperuricemia[J].Mol Ther Nucleic Acids,2021,25:578-584.[19]Lin A,Sun Z,Xu X,et al.Self-Cascade Uricase/Catalase Mimics Alleviate Acute Gout[J].Nano Lett,2022,22(1):508-516.[20]Takahashi T,Beppu T,Hidaka Y,et al.Comparative study of a novel selective urate reabsorption inhibitor "dotinurad" among patient groups with different stages of renal dysfunction[J].Clin Exp Nephrol,2021,25(12):1336-1345.
相似文献/References:
[1]王立民,刘有旺,王恩波,等.以大黄素为声敏剂介导声动力疗法对小鼠
动脉粥样硬化治疗作用的研究[J].医学信息,2018,31(06):58.[doi:10.3969/j.issn.1006-1959.2018.06.019]
WANG Li-min,LIU You-wang,WANG En-bo,et al.Study on the Effect of Emodin on the Treatment of Atherosclerosis in Mice[J].Journal of Medical Information,2018,31(12):58.[doi:10.3969/j.issn.1006-1959.2018.06.019]
[2]杨玉媛,刘有旺,李 腾,等.Th17细胞对动脉粥样硬化斑块易损性和斑块破裂的影响研究[J].医学信息,2018,31(18):53.[doi:10.3969/j.issn.1006-1959.2018.18.017]
YANG Yu-yuan,LIU You-wang,LI Teng,et al.Effect of Th17 Cells on Atherosclerotic Plaque Vulnerability and Plaque Rupture[J].Journal of Medical Information,2018,31(12):53.[doi:10.3969/j.issn.1006-1959.2018.18.017]
[3]陈玉媛,易爱姣,谭齐鸣,等.中青年冠状动脉粥样硬化患者颈动脉硬化的超声特征[J].医学信息,2019,32(02):175.[doi:10.3969/j.issn.1006-1959.2019.02.054]
CHEN Yu-yuan,YI Ai-jiao,TAN Qi-ming,et al.Ultrasound Characteristics of Carotid Atherosclerosis in Young and Middle-aged Patients with Coronary Atherosclerosis[J].Journal of Medical Information,2019,32(12):175.[doi:10.3969/j.issn.1006-1959.2019.02.054]
[4]郝冬冬,高 宇.C肽与动脉粥样硬化的相关性研究[J].医学信息,2019,32(09):28.[doi:10.3969/j.issn.1006-1959.2019.09.010]
HAO Dong-dong,GAO Yu.Correlation between C-peptide and Atherosclerosis[J].Journal of Medical Information,2019,32(12):28.[doi:10.3969/j.issn.1006-1959.2019.09.010]
[5]严文文,陈 然,金 平,等.老年患者颅内动脉粥样硬化性狭窄的分布和危险因素研究[J].医学信息,2019,32(09):78.[doi:10.3969/j.issn.1006-1959.2019.09.025]
YAN Wen-wen,CHEN Ran,JIN Ping,et al.Distribution and Risk Factors of Intracranial Atherosclerotic Stenosis in Elderly Patients[J].Journal of Medical Information,2019,32(12):78.[doi:10.3969/j.issn.1006-1959.2019.09.025]
[6]李慧丹,赵文鸽,王学惠.Nox4在同型半胱氨酸介导的动脉粥样硬化中作用的研究[J].医学信息,2019,32(15):45.[doi:10.3969/j.issn.1006-1959.2019.15.015]
LI Hui-dan,ZHAO Wen-ge,WANG Xue-hui.Research on the Role of Nox4 in Homocysteine-mediated Atherosclerosis[J].Journal of Medical Information,2019,32(12):45.[doi:10.3969/j.issn.1006-1959.2019.15.015]
[7]薛 一,孔莫维,高 宇.脂蛋白相关磷脂酶A2与冠心病的研究[J].医学信息,2019,32(12):53.[doi:10.3969/j.issn.1006-1959.2019.12.017]
XUE Yi,KONG Mo-wei,GAO Yu.Research on Lipoprotein-associated Phospholipase A2 and Coronary Heart Disease[J].Journal of Medical Information,2019,32(12):53.[doi:10.3969/j.issn.1006-1959.2019.12.017]
[8]黄梦倩,张瑞恒,刘楚浩,等.影像组学在神经系统疾病中的应用研究[J].医学信息,2019,32(16):47.[doi:10.3969/j.issn.1006-1959.2019.16.015]
HUANG Meng-qian,ZHANG Rui-heng,LIU Chu-hao,et al.Application of Radiomics in Nervous System Diseases[J].Journal of Medical Information,2019,32(12):47.[doi:10.3969/j.issn.1006-1959.2019.16.015]
[9]高诗奇,邓代华,杨 静.成纤维细胞生长因子21抗动脉粥样硬化作用的研究[J].医学信息,2020,33(19):28.[doi:10.3969/j.issn.1006-1959.2020.19.009]
GAO Shi-qi,DENG Dai-hua,YANG Jing.Study on Anti-atherosclerosis Effect of Fibroblast Growth Factor 21[J].Journal of Medical Information,2020,33(12):28.[doi:10.3969/j.issn.1006-1959.2020.19.009]
[10]张 蕊,耿 佳,王雪梅.长链非编码RNA在内皮细胞损伤模型中的表达调控研究[J].医学信息,2020,33(22):71.[doi:10.3969/j.issn.1006-1959.2020.22.022]
ZHANG Rui,GENG Jia,WANG Xue-mei.Study on the Expression Regulation of Long Non-coding RNA in Endothelial Cell Injury Model[J].Journal of Medical Information,2020,33(12):71.[doi:10.3969/j.issn.1006-1959.2020.22.022]